OSLO, Norway, June 10, 2020 /PRNewswire/ -- Photocure ASA (OSE: PHO), held its annual general meeting on 10 June 2020 at 17:00 hours (CET).
All proposals were resolved as presented in the notice convening the annual general meeting dated 19 May 2020, as further set out in the minutes from the general meeting attached hereto.
For further information, please contact:
Photocure
CFO Erik Dahl
Tel: + 47-450-55-000
Email: ed@photocure.no
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, which makes cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com or www.cysview.com.
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/photocure/r/photocure-asa---annual-general-meeting-held,c3131877
The following files are available for download:
https://mb.cision.com/Main/17498/3131877/1262288.pdf | Release |
https://mb.cision.com/Public/17498/3131877/a8f875ada6a51828.pdf | PHO - Protokoll OGF 2020 |
